Up‐regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brain

Increased binding of the peripheral benzodiazepine binding site (PBBS) ligand [3H]PK11195 in the central nervous system of patients suffering from acute and chronic neuropathology has been associated with reactive microgliosis. However, it remains uncertain which stages of microglial activation occur in conjunction with the increased [3H]PK11195 binding. We used quantitative autoradiography for [3H]PK11195 and quantitative polymerase chain reaction for PBBS mRNA and markers of early and late microglial activation to investigate the time‐course of cellular responses in the hippocampus of mice with degeneration of the entorhinal‐hippocampal perforant path. The axonal lesion evoked an increase in the Bmax for [3H]PK11195 in hippocampus which peaked at 2 days post‐lesion, remained elevated at day 5 and began to decline at 10 days post‐lesion. These changes occurred in the absence of significant changes in affinity in vitro. Quantitative polymerase chain reaction analysis of isolated hippocampi using exon‐specific primers indicated the presence of several splice variants of PBBS mRNA, which appeared to be affected differentially by the lesion. The changes in PBBS mRNA and CD11b mRNA levels correlated with the Bmax for [3H]PK11195 during 10 days post‐lesion, suggesting that microglial activation couples with increases in mRNA levels for these markers. In addition, the onset of changes in PBBS mRNA levels coincided with the significantly elevated tumor necrosis factor mRNA levels present during early microglial activation at 2 days post‐lesion. We conclude that up‐regulation of [3H]PK11195 binding and PBBS mRNA levels coincided with early microglial activation, characterized by concomitantly increased microglial tumor necrosis factor mRNA levels, and persisted throughout the period with reactive microgliosis.

[1]  V. Perry,et al.  Turnover of resident microglia in the normal adult mouse brain , 1992, Neuroscience.

[2]  V. Papadopoulos,et al.  Modulation of peripheral-type benzodiazepine receptor levels in a reperfusion injury pig kidney-graft model1 , 2002, Transplantation.

[3]  Abraham Weizman,et al.  PK 11195 attenuates kainic acid‐induced seizures and alterations in peripheral‐type benzodiazepine receptor (PBR) protein components in the rat brain , 2002, Journal of neurochemistry.

[4]  Richard B. Banati,et al.  Ligands for peripheral benzodiazepine binding sites in glial cells , 2005, Brain Research Reviews.

[5]  A. Fagan,et al.  Mechanisms of sprouting in the adult central nervous system: Cellular responses in areas of terminal degeneration and reinnervation in the rat hippocampus , 1994, Neuroscience.

[6]  H. Park,et al.  Effects of peripheral benzodiazepine receptor ligands on proliferation and differentiation of human mesenchymal stem cells , 2004, Journal of cellular physiology.

[7]  R. Dempsey,et al.  Up‐regulation of the peripheral‐type benzodiazepine receptor expression and [3H]PK11195 binding in gerbil hippocampus after transient forebrain ischemia , 2001, Journal of neuroscience research.

[8]  R. Butterworth,et al.  Peripheral benzodiazepine binding sites in Alzheimer's disease frontal and temporal cortex , 1991, Neurobiology of Aging.

[9]  G. Deuschl,et al.  Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro , 2003, Neurobiology of Disease.

[10]  Alexander Gerhard,et al.  Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study , 2005, NeuroImage.

[11]  J. Zimmer,et al.  Microglial and astroglial reactions to anterograde axonal degeneration: a histochemical and immunocytochemical study of the adult rat fascia dentata after entorhinal perforant path lesions , 2004, Experimental Brain Research.

[12]  F. Poulsen,et al.  Microglial reactivity correlates to the density and the myelination of the anterogradely degenerating axons and terminals following perforant path denervation of the mouse fascia dentata , 1999, Neuroscience.

[13]  Paul Cumming,et al.  Distribution of PK11195 binding sites in porcine brain studied by autoradiography in vitro and by positron emission tomography , 2006, Synapse.

[14]  V. Papadopoulos,et al.  In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. , 2003, Biochemistry.

[15]  M. Gavish,et al.  Biochemical, Physiological, and Pathological Aspects of the Peripheral Benzodiazepine Receptor , 1992, Journal of neurochemistry.

[16]  J. Korf,et al.  Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study , 2005, Multiple sclerosis.

[17]  L. Garcia-Segura,et al.  Ro5‐4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity , 2005, Journal of neuroscience research.

[18]  T. Guilarte,et al.  Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. , 2004, Brain : a journal of neurology.

[19]  R B Banati,et al.  PK (‘peripheral benzodiazepine’) – binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK 11195 binding to activated microglia , 1997, Journal of neurocytology.

[20]  G. Kreutzberg,et al.  Mitochondria in activated microglia in vitro , 2004, Journal of neurocytology.

[21]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[22]  V. Perry,et al.  Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain , 1985, Neuroscience.

[23]  R B Banati,et al.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.

[24]  Gary Lynch,et al.  An electron microscopic study of lesion-induced synaptogenesis in the dentate gyrus of the adult rat. I. Magnitude and time course of degeneration , 1976, Brain Research.

[25]  Hyun B Choi,et al.  Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum , 2005, Neurobiology of Disease.

[26]  J. Ryu,et al.  Inhibition of lipopolysaccharide‐induced cyclooxygenase‐2, tumor necrosis factor‐α and [Ca2+]i responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195 , 2002, Journal of neurochemistry.

[27]  B. Castellano,et al.  Morphology and distribution of microglial cells in the young and adult mouse cerebellum , 1995, The Journal of comparative neurology.

[28]  E. Yoshikawa,et al.  Microglial activation and dopamine terminal loss in early Parkinson's disease , 2005, Annals of neurology.

[29]  Roger N Gunn,et al.  In-vivo measurement of activated microglia in dementia , 2001, The Lancet.

[30]  B. Finsen,et al.  IFNγ Enhances Microglial Reactions to Hippocampal Axonal Degeneration , 2000, The Journal of Neuroscience.

[31]  M. Höpfner,et al.  Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human esophageal cancer cells. , 2001, International journal of cancer.

[32]  Y. Itoyama,et al.  Cell cycle protein expression in proliferating microglia and astrocytes following transient global cerebral ischemia in the rat , 2003, Brain Research Bulletin.

[33]  K. Lambertsen,et al.  Validation of two reference genes for mRNA level studies of murine disease models in neurobiology , 2006, Journal of Neuroscience Methods.

[34]  J. Zimmer,et al.  Microglial MHC antigen expression after ischemic and kainic acid lesions of the adult rat hippocampus , 1993, Glia.

[35]  P. Casellas,et al.  Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage. , 1996, Blood.

[36]  M. Wirenfeldt,et al.  Microglial cell population dynamics in the injured adult central nervous system , 2005, Brain Research Reviews.

[37]  R. Cheney,et al.  Expression of the peripheral benzodiazepine receptor is decreased in skin cancers in comparison with normal skin , 2004, The British journal of dermatology.

[38]  M. Pallàs,et al.  Evidence in favour of a role for peripheral-type benzodiazepine receptor ligands in amplification of neuronal apoptosis , 2005, Apoptosis.

[39]  V. Papadopoulos,et al.  Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis , 1997, Steroids.

[40]  D. Stephenson,et al.  Increased expression of peripheral benzodiazepine receptors in the facial nucleus following motor neuron axotomy , 1997, Neurochemistry International.

[41]  J. Zimmer,et al.  Microglial and Astroglial Reactions to Ischemic and Kainic Acid-Induced Lesions of the Adult Rat Hippocampus , 1993, Experimental Neurology.

[42]  R. Nitsch,et al.  Proliferation of microglia and astrocytes in the dentate gyrus following entorhinal cortex lesion: a quantitative bromodeoxyuridine‐labelling study , 1999, The European journal of neuroscience.

[43]  R. Gregersen,et al.  Proliferating resident microglia express the stem cell antigen CD34 in response to acute neural injury , 2005, Glia.

[44]  M. Norenberg,et al.  Characterization of the peripheral‐type benzodiazepine receptors in cultured astrocytes: Evidence for multiplicity , 1993, Glia.

[45]  R. Anholt,et al.  The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. , 1986, The Journal of biological chemistry.

[46]  D. Howells,et al.  Tissue fixation prevents contamination of tritium-sensitive storage phosphor imaging plates. , 1999, BioTechniques.

[47]  R. Banati,et al.  Visualising microglial activation in vivo , 2002, Glia.

[48]  C. Colton,et al.  Species differences in the generation of reactive oxygen species by microglia , 1996, Molecular and chemical neuropathology.

[49]  M. Zoratti,et al.  The mitochondrial permeability transition pore may comprise VDAC molecules , 1993, FEBS letters.

[50]  I. Bechmann,et al.  CXCR3-Dependent Microglial Recruitment Is Essential for Dendrite Loss after Brain Lesion , 2004, The Journal of Neuroscience.

[51]  W. Kuziel,et al.  Chemokine Expression by Glial Cells Directs Leukocytes to Sites of Axonal Injury in the CNS , 2003, The Journal of Neuroscience.

[52]  K. Lambertsen,et al.  Reactive microgliosis engages distinct responses by microglial subpopulations after minor central nervous system injury , 2005, Journal of neuroscience research.

[53]  S. Snyder,et al.  Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[54]  I. Artemenko,et al.  Regulation of cholesterol movement to mitochondrial cytochrome P450scc in steroid hormone synthesis , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[55]  W L Miller,et al.  The human peripheral benzodiazepine receptor gene: cloning and characterization of alternative splicing in normal tissues and in a patient with congenital lipoid adrenal hyperplasia. , 1993, Genomics.

[56]  M. Graeber,et al.  Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells , 1988, Journal of neuroscience research.

[57]  R. Dempsey,et al.  Traumatic Brain Injury Leads to Increased Expression of Peripheral-Type Benzodiazepine Receptors, Neuronal Death, and Activation of Astrocytes and Microglia in Rat Thalamus , 2000, Experimental Neurology.

[58]  G. Lynch,et al.  Proliferative and migratory activity of glial cells in the partially deafferented hippocampus , 1979, The Journal of comparative neurology.